organisms from the respiratory tract. She reported multiple respiratory tract infections during her childhood years in Tennessee. Over the past 5 years, she had had recurrent dyspnea, right-sided chest pain, and productive cough. Because of progressive symptoms and a new infiltrate in the right middle lobe, a bronchoscopy was done in November 1992. Culture of the endobronchial wash yielded MAC organisms. Over the next 2 years, she noted increasing fatigue, dyspnea, and cough and there was persistence of the right middle lobe infiltrate with progression to involve the right lower lobe. Computed tomography (CT) revealed large calcified pretracheal, subcranial, right hilar lymph nodes and splenic calcifications; in addition, bronchiectasis and nodular opacities were noted in the right middle lobe and the superior segment of the right lower lobe, regions subserved by the airways involved with the adenopathy (Fig 1, A) . Transbronchial biopsy of the right middle lobe showed chronic bronchitis with granulomatous inflammation. Stains for acid-fast bacteria were negative, but MAC was recovered from sputum, bronchial wash, and transbronchial biopsy cultures. Treatment was initiated with clarithromycin, ethambutol, rifampin, and clofazimine.
Case 2.
A 79-year-old woman, diagnosed with pulmonary MAC disease 3 years earlier, was evaluated for continued symptoms of weight loss, productive cough, and diminished exercise tolerance despite previous treatment with clarithromycin, rifampin, and ciprofloxacin. Chest radiograph revealed nodule formation, hazy opacities, and bronchiectasis in the right upper lobe, right middle lobe, lingula, and superior segments of both lower lobes. Computed tomography of the chest revealed the disease was most apparent in the superior segment of the right lower lobe with a large thick-walled cavity. Most notably, a large calcific node compressed the lumen of the corresponding superior segment bronchus (Fig 1, B) . A residential history revealed that she had lived for an extended time in Illinois in a region known to be endemic for histoplasmosis.
METHODS
The earliest chest roentgenograms and computed tomograms of patients who were referred between January and December 1993 to the National Jewish Medical and Research Center for evaluation of pulmonary MAC disease were reviewed for the presence of calcified thoracic lymphadenopathy and of splenic calcification. Records were reviewed for known predispositions for pulmonary MAC disease. The frequency of no identifiable risk factor was compared between patients with and without calcified lymphadenopathy by chisquare analysis. Patients were also interviewed by telephone to determine the city and state in which they had resided the longest before their diagnosis of pulmonary MAC disease. The residential pattern generated (Fig 2) was compared with the distribution of skin test reactivity to histoplasmin in the survey of over A B FIGURE 2. Map shows residential distribution of 79 study patients with (q, n = 25) and without (r, n = 51) thoracic lymph node calcifications and three patients with isolated splenic calcifications (q q).
270,000 US Navy recruits who had been lifetime one-county residents (Fig 3) .
RESULTS
Of the 94 patients (71 females, 23 males) seen for pulmonary disease due to MAC during 1993, 14 were excluded because adequate radiographs were not available (n = 3) or we were unable to contact them to record residential histories (n = 11). One patient was excluded from the analysis because she was a lifetime resident from Italy, though she did have calcified thoracic adenopathy. This left 79 patients with pulmonary MAC disease for analyses. All patients met the established diagnostic criteria for pulmonary MAC disease, namely, repeated sputum or lung biopsy cultures positive for MAC and negative for other pathogens, including endemic or opportunistic fungi and suitable radiographic abnormalities typically involving cylindrical and varicoid bronchiectasis, nodular shadowing, and/or cavitary infiltrates. 1, 7 Nearly two thirds (51/79, 65%) of the patients with pulmonary MAC had no identifiable classic risk factor (Table  1) . When sub-categorized according to sex and the presence or absence of risk factors (Table 1) , the proportion of females with classic risk factors (17/60, 28%) is significantly less than the proportion of males with such risk factors (11/19, 58%, P = .02).
One third of the patients (25/79, 32%) had significant calcified mediastinal and/or hilar lymphadenopathy ( Table 2) ; eight of these patients also had splenic calcifications. Three patients had isolated splenic calcification without visible chest adenopathy. Twenty-eight patients (35%) were identified by chart review and by interview to have a classic risk factor for MAC pulmonar y disease ( Table 2) . Inspection of the distribution of patients with calcified adenopathy showed concordance of this finding with regions known to be endemic for histoplasmosis (Figs 2 and 3) . Nineteen of these 25 patients (76%) with calcified chest adenopathy had no known predisposing risk factor for the infection. The proportion of patients with no calcified adenopathy who also had no identifiable risk factor tended to be lower (32/54, 59%), though this difference did not reach statistical significance (P = .15).
DISCUSSION
Mycobacterium avium complex is widely distributed in the environment, and aerosolization of MAC from the soil and natural water sources is considered a potential mode of pulmonary infection. 1, 8, 9 Because the disease is relatively uncommon despite the presumption of widespread exposure, the prevailing hypothesis on its pathogenesis entails local or diffuse anatomic defects in the lungs of those who have disease. 10 In early series, the major identified risk factor for the acquisition of pulmonar y MAC disease was the presence of emphysema or chronic bronchitis, predominantly in middle-aged and elderly white men. 11 Other associated disorders include silicosis, previous tuberculosis, and fibrosis associated with ankylosing spondylitis or rheumatoid arthritis.
12, 13 Reich and Johnson 14 studied 29 patients from a nonreferral population and noted a high incidence (21%) of disease limited to the lingula or middle lobe, suggesting a local anatomic defect. A recent report noted Risk factors: chronic obstructive pulmonary disease (14) , emphysema and pectus excavatum (1), pectus excavatum alone (3), previous tuberculosis (5), previous bronchiectasis from pertussis (2) , familial history of bronchiectasis and infertility (1), and previous gastrectomy (2) . 
275,558 NAVY RECRUITS
1958 -1965 white males 17-21 years LIFETIME ONE COUNTY RESIDENTS an even higher incidence (73%) of disease in the right middle lobe and/or the lingular lobe in a group of patients identified in a community practice. 2 Moreover, both studies also noted a high incidence of women with no classic predisposing conditions, findings consistent with the results of our study (Table 1) .
In areas of the United States endemic for H capsulatum, principally the Midwest along the Missouri, Mississippi, and Ohio river valleys, calcified chest nodes are frequently the result of past infection with this organism. Sequelae of acute pulmonary histoplasmosis include enlargement and calcification of hilar and mediastinal lymph nodes, which may cause local complications, including broncholithiasis, hemoptysis, obstructive pneumonitis, and tracheoesophageal fistulas. 15 We speculate that calcified intrathoracic lymphadenopathy may mark individuals at risk for pulmonary MAC infection due to lung damage from previous infection by H capsulatum. Based on our CT and bronchoscopic findings, localized parenchymal damage was evident in some cases; in others, proximal bronchial distortion or compression may have contributed to creating an environment conducive to colonization and invasion by the mycobacteria.
Our preliminary observations indicate that, among patients with pulmonary MAC infection and calcified chest adenopathy, there is a higher proportion who have no classic risk factors (19/25, 79%) compared with those who have no such adenopathy (32/54, 59%). Although this comparison did not reach a statistically significant difference, this trend might have achieved significance in a larger sample size. However, an equally plausible though not mutually exclusive explanation is that there are other risk factors for pulmonary MAC that are yet to be identified, including those that are not attributable to the host such as the dose of inoculation of the organism. One observation that we made, which would lend credence to this latter hypothesis, is that in the no-risk factor group, most of the patients had no calcified intrathoracic adenopathy (32/51) ( Table 2 ). Unfortunately, due to the retrospective nature of the study, histoplasmin skin testing was not done. Although not useful in the diagnosis of acute histoplasmosis, skin testing may help to validate or refute our observation that patients with pulmonar y MAC and calcified chest adenopathy principally reside in the endemic regions of histoplasmosis and that those without such adenopathy do not reside in such areas. Although we assumed that MAC infection does not cause such gross calcification, the similarity of distribution of patients with calcified chest nodes to that of a large group of healthy individuals with positive reaction to histoplasmin is compatible with the hypothesis that the calcified chest nodes in the study patients were due to histoplasmosis. 4 Furthermore, the infrequency of such calcifications in those patients who have never resided in regions endemic for histoplasmosis also indirectly supports our hypothesis (Fig 2) .
Although it might be argued that our hypothesis of this putative association between these two infections is merely coincidental, we submit that the following factors militate against that argument: (1) the frequency of large, calcified nodes is higher than would be expected of a random sample of residents of the histoplasmosis region; (2) although the distribution of the relative frequency of pulmonary MAC disease vs the endemic region of histoplasmosis overlap, the former is most intensely confined to the coastal region of southeastern United States, whereas histoplasmosis is mostly concentrated in the Midwest region; (3) there is a relatively greater portion of persons with calcified adenopathy who have no other MAC risk factors; and (4) the pulmonary MAC disease tends to be localized to regions that drain into these lymph nodes or are subserved by airways involved with the peribronchial adenitis.
CONCLUSION
We have found that in a large referral population of pulmonary MAC patients, the majority do not have an identifiable risk factor for MAC disease. Although we have not established a definite causal relationship between the putative histoplasmosis and MAC disease in this retrospective study, our preliminary observations may pique the interest of clinicians who practice in the histoplasmosis belt to do more definitive studies. A long-term prospective investigation using histoplasmin skin-testing, serologic surveys, detailed residential histories, and focused analysis of regional calcified adenopathy and the anatomic distribution of MAC lung disease would help clarify this potential relationship.
